Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

“Big Fat” complaint

This article was originally published in The Tan Sheet

Executive Summary

Ines Arroyo has been added to a complaint against Femina Inc. et al. by a unanimous vote, FTC announces Feb. 22. The original complaint, filed in November, alleged the defendants used deceptive marketing for weight-loss products 1-2-3 Reduce Fat, Siluette [sic]Patch and Fat Seltzer Reduce (1"The Tan Sheet" Nov. 15, 2004, p. 14). The Commission's complaint is part of the "Big Fat Lie" campaign against false marketing for weight-loss supplements...

You may also be interested in...



“Operation Big Fat Lie”: FTC Files Suits, Fights Bogus Weight-Loss Ads

FTC's "Red Flag" initiative has roughly halved the number of ads with fraudulent weight-loss claims since its inception, according to the commission

Corindus Envisions Network Of CorPath Robots For Remote Neurovascular And Coronary Interventions

The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.

MTI Top 100: Leading Medtechs See Steady Organic Growth In A Market On The Cusp Of Change

The disruptive medtech M&A of recent years was not matched in the past year for volume, but there were isolated outbreaks of major activity, as shown in our company rankings. 

Topics

UsernamePublicRestriction

Register

PS097887

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel